| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |